|
| 38095433 | Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions". | mBio | 2024 |
| 38019656 | Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls. | J Infect Dis | 2024 |
| 38009954 | COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial. | Microbiol Spectr | 2024 |
| 37036339 | SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters. | | 2023 |
| 36366857 | Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization. | Clinical Infectious Diseases | 2023 |
| 35579509 | Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. | Clin Infect Dis | 2023 |
| 36150651 | Developing and validating clinical features-based machine learning algorithms to predict influenza infection in influenza-like illness patients. | Biomed J | 2023 |
| 36268708 | Absence of pathogenic viruses in COVID-19 convalescent plasma. | Transfusion | 2023 |
| 37766362 | The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection-Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures. | Viruses | 2023 |
| 37674985 | Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells. | iScience | 2023 |
| 38022602 | Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies. | | 2023 |
| 37659419 | Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. | Lancet Microbe | 2023 |
| 38014049 | Application of machine learning models to identify serological predictors of COVID-19 severity and outcomes. | | 2023 |
| 37724870 | Early antibody treatment, inflammation, and risk of post-COVID conditions. | mBio | 2023 |
| 37577692 | Growth media affects susceptibility of air-lifted human nasal epithelial cell cultures to SARS-CoV2, but not Influenza A, virus infection. | | 2023 |
| 37577630 | The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures. | bioRxiv | 2023 |
| 38088981 | Evolution of Influenza A(H3N2) Viruses in 2 Consecutive Seasons of Genomic Surveillance, 2021-2023. | | 2023 |
| 37872306 | Author Correction: 2019-2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade. | | 2023 |
| 37858626 | Discovery, validation, and prodrug design of an ACE2 activator for treating bacterial infection-induced lung inflammation. | | 2023 |
| 36906295 | Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients. | Am J Transplant | 2023 |
| 36966905 | Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose. | Am J Transplant | 2023 |
| 36773929 | Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses. | | 2023 |
| 36773622 | Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate. | Lancet Infect Dis | 2023 |
| 36824860 | Early Treatment, Inflammation and Post-COVID Conditions. | medRxiv | 2023 |
| 37131659 | Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial. | medRxiv | 2023 |
| 36945583 | Early transcriptional responses of human nasal epithelial cells to infection with Influenza A and SARS-CoV-2 virus differ and are influenced by physiological temperature. | | 2023 |
| 36875207 | Antiviral effect and mechanism of Phillyrin and its reformulated FS21 against influenza. | | 2023 |
| 36700653 | Virology under the Microscope-a Call for Rational Discourse. | mSphere | 2023 |
| 36700642 | Virology under the Microscope-a Call for Rational Discourse. | mBio | 2023 |
| 36700640 | Virology under the Microscope-a Call for Rational Discourse. | J Virol | 2023 |
| 37255467 | SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022. | Transfusion | 2023 |
| 36480419 | Applying symptom dynamics to accurately predict influenza virus infection: An international multicenter influenza-like illness surveillance study. | Influenza Other Respir Viruses | 2023 |
| 37441773 | Diagnostic accuracy of clinical signs and symptoms of COVID-19: A systematic review and meta-analysis to investigate the different estimates in a different stage of the pandemic outbreak. | J Glob Health | 2023 |
| 36865250 | 2019-20 H1N1 clade A5a.1 viruses have better <i>in vitro</i> replication compared with the co-circulating A5a.2 clade. | bioRxiv | 2023 |
| 36993658 | Adverse outcomes in SARS-CoV-2 infected pregnant mice are gestational age-dependent and resolve with antiviral treatment. | | 2023 |
| 36468309 | Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain Reaction. | J Infect Dis | 2023 |
| 36993205 | Integrated Drivers of Basal and Acute Immunity in Diverse Human Populations. | bioRxiv | 2023 |
| 37428037 | Accuracy of Expired BinaxNOW Rapid Antigen Tests. | | 2023 |
| 37354908 | Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization. | Cell Chem Biol | 2023 |
| 37353648 | 2019-2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade. | Sci Rep | 2023 |
| 36986402 | Early Transcriptional Responses of Human Nasal Epithelial Cells to Infection with Influenza A and SARS-CoV-2 Virus Differ and Are Influenced by Physiological Temperature. | | 2023 |
| 36531610 | Supramolecular filaments for concurrent ACE2 docking and enzymatic activity silencing enable coronavirus capture and infection prevention. | | 2023 |
| 37534607 | Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials. | Transfusion | 2023 |
| 37533553 | Respiratory viruses in rural Zambia during the second year of the COVID-19 pandemic. | IJID Reg | 2023 |
| 37504520 | SARS-CoV-2 infection alters mitochondrial and cytoskeletal function in human respiratory epithelial cells mediated by expression of spike protein. | | 2023 |
| 37498190 | Successful liver transplantation from deceased donors with active COVID-19 infections with undetectable SARS-CoV-2 in donor liver and aorta. | | 2023 |
| 35327055 | Characteristics of SARS-CoV-2 Seropositivity among Emergency Department Healthcare Workers at a Tertiary Care Center in Baltimore. | Healthcare (Basel) | 2022 |
| 35460989 | The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads. | eBioMedicine | 2022 |
| 36172137 | Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization. | | 2022 |
| 35649381 | Antigenic and virological properties of an H3N2 variant that continues to dominate the 2021-22 Northern Hemisphere influenza season. | Cell Reports | 2022 |